Published in Exp Neurol on October 01, 1997
Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol (2009) 2.06
Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One (2010) 1.41
Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol Ther (2007) 1.17
Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol Psychiatry (2012) 1.11
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation. Mol Neurodegener (2010) 0.90
Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain. J Biol Chem (2011) 0.89
Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin. Int J Nanomedicine (2015) 0.79
Epigenetic induction of EGR-1 expression by the amyloid precursor protein during exposure to novelty. PLoS One (2013) 0.78
Alzheimer's disease and brain development: common molecular pathways. Front Biosci (1998) 0.78
Early Growth Response 1 (Egr-1) Is a Transcriptional Activator of β-Secretase 1 (BACE-1) in the Brain. J Biol Chem (2016) 0.75
Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease. Front Mol Neurosci (2016) 0.75
The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience (1989) 3.57
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med (1999) 2.78
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Increased summertime UV radiation in New Zealand in response to ozone loss. Science (1999) 2.11
Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res (1997) 2.08
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (2000) 2.03
An ethics core curriculum for Australasian medical Schools. Med J Aust (2001) 1.95
Community nursing: how dependent are stroke patients? Nurs Mirror (1978) 1.85
Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol (2000) 1.82
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev (1995) 1.81
Neuroprotective effects of adenosine. Trends Pharmacol Sci (1988) 1.69
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br J Cancer (2006) 1.66
The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev (1998) 1.64
Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol Brain Res (2001) 1.60
Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience (1978) 1.57
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience (2000) 1.55
Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry (2000) 1.54
The energetic cost of limbless locomotion. Science (1990) 1.49
Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust (1990) 1.44
The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol (1991) 1.41
Caring for patients with enterocutaneous fistulae. Br J Nurs (1992) 1.40
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun (1992) 1.39
Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum. J Comp Neurol (2000) 1.34
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone. Oncogene (2000) 1.34
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther (2001) 1.34
Hepatitis A booster vaccination: is there a need? Lancet (2003) 1.32
Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience (1996) 1.30
Degenerative joint disease in the mouse knee; radiological and morphological observations. J Pathol (1977) 1.29
Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuroscience (2004) 1.27
Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience (1993) 1.26
Evaluation of the BACTEC MGIT 960 system for the recovery of mycobacteria. Diagn Microbiol Infect Dis (2000) 1.26
Degenerative joint disease in the mouse knee; histological observations. J Pathol (1977) 1.24
CREB phosphorylation promotes nerve cell survival. J Neurochem (1999) 1.24
Nonsyndromic cleft lip and palate: no evidence of linkage to HLA or factor 13A. Am J Hum Genet (1993) 1.23
A double dissociation within the hippocampus of dopamine D1/D5 receptor and beta-adrenergic receptor contributions to the persistence of long-term potentiation. Neuroscience (1999) 1.22
The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience (2005) 1.21
Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res (1995) 1.20
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol (1997) 1.18
Long-term morphology of a healing bone-tendon interface: a histological observation in the sheep model. J Anat (2007) 1.15
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog Neurobiol (1999) 1.13
Diagnosis of asbestosis by needle lung biopsy. Thorax (1968) 1.12
Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab (2001) 1.12
In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport (1995) 1.12
The relation of Vmax to INa, GNa, and h infinity in a model of the cardiac Purkinje fiber. Biophys J (1979) 1.09
D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience (1990) 1.09
Button-pexy fixation for repair of ileostomy and colostomy prolapse. J Pediatr Surg (1995) 1.09
Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res (1998) 1.09
Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus. Neuroscience (2001) 1.06
The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res (1987) 1.05
Precision genetics for complex objectives in animal agriculture. J Anim Sci (2010) 1.04
Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics (2001) 1.03
Doublecortin expression in the normal and epileptic adult human brain. Eur J Neurosci (2008) 1.02
Is adenosine an endogenous anticonvulsant? Epilepsia (1985) 1.02
Characterization of [(3)H]Quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections. J Neurochem (2000) 1.02
The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Brain Res Mol Brain Res (1996) 1.02
Correlation between the induction of an immediate early gene, zif/268, and long-term potentiation in the dentate gyrus. Brain Res (1992) 1.01
Creating a "no blame" culture: have we got the balance right? Qual Saf Health Care (2004) 1.01
N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res (2000) 1.01
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol (2000) 1.01
Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum. Neuroscience (1998) 1.01
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer Chemother Pharmacol (2005) 1.01
Loss of A1 adenosine receptors in human temporal lobe epilepsy. Brain Res (1996) 1.00
Connexin expression in Huntington's diseased human brain. Cell Biol Int (1998) 1.00
Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience (1996) 1.00
Changes in subarachnoid hemorrhage mortality, incidence, and case fatality in New Zealand between 1981-1983 and 1991-1993. Stroke (1998) 1.00
Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease. Brain Res Bull (2001) 1.00
Krox20 may play a key role in the stabilization of long-term potentiation. Brain Res Mol Brain Res (1995) 0.99
Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Brain Res Rev (1999) 0.99
Amyloid-like inclusions in Huntington's disease. Neuroscience (2000) 0.99
Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? Brain Res Mol Brain Res (1993) 0.99
Clinical anticancer drug development: targeting the cyclin-dependent kinases. Br J Cancer (2005) 0.99
Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Neuroscience (2007) 0.99
Patella displacement and osteoarthrosis of the knee joint in mice. J Pathol (1979) 0.99
Testicular fate after incarcerated hernia repair and/or orchiopexy performed in patients under 6 months of age. J Pediatr Surg (1995) 0.99
Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport (2000) 0.98
GABA(B) receptor heterodimer-component localisation in human brain. Brain Res Mol Brain Res (2000) 0.97
Population genetics of the yellow fever mosquito in Trinidad: comparisons of amplified fragment length polymorphism (AFLP) and restriction fragment length polymorphism (RFLP) markers. Mol Ecol (1999) 0.97
Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. Brain Res Mol Brain Res (1994) 0.96
Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study. Neuroscience (1990) 0.96